Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Current Taxes (2016 - 2025)

Historic Current Taxes for Sanofi (SNY) over the last 11 years, with Q4 2025 value amounting to $874.3 million.

  • Sanofi's Current Taxes rose 1738.23% to $874.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $874.3 million, marking a year-over-year increase of 1738.23%. This contributed to the annual value of $848.7 million for FY2025, which is 1250.24% up from last year.
  • Sanofi's Current Taxes amounted to $874.3 million in Q4 2025, which was up 1738.23% from $819.5 million recorded in Q2 2025.
  • Sanofi's Current Taxes' 5-year high stood at $874.3 million during Q4 2025, with a 5-year trough of $142.1 million in Q2 2024.
  • In the last 5 years, Sanofi's Current Taxes had a median value of $614.0 million in 2022 and averaged $575.4 million.
  • Its Current Taxes has fluctuated over the past 5 years, first plummeted by 6537.38% in 2024, then skyrocketed by 47653.43% in 2025.
  • Quarter analysis of 5 years shows Sanofi's Current Taxes stood at $353.5 million in 2021, then surged by 65.67% to $585.6 million in 2022, then grew by 9.68% to $642.3 million in 2023, then rose by 15.95% to $744.8 million in 2024, then rose by 17.38% to $874.3 million in 2025.
  • Its Current Taxes was $874.3 million in Q4 2025, compared to $819.5 million in Q2 2025 and $744.8 million in Q4 2024.